Latest Info
8.12.2009
- Incyte: Announcement of a major partnership with Novartis
- BioXell: Support of the planned acquisition by Cosmo Pharmaceuticals
10.11.2009
- Vertex announces impressive Telaprevir data at the AASLD Meeting
- Actelion reports solid 9-months financial results
- Arena - 2nd Phase III trial confirms efficacy and safety of Lorcaserin
29.10.2009
BB BIOTECH: Positive performance in the third quarter 2009
12.10.2009
- BB BIOTECH: Initiation of 6th share buyback on September 16, 2009
- Incyte: Positive Phase II results for its lead JAK inhibitor in patients with mild-to-moderate psoriasis
- Arena: 2nd Phase III study confirms efficacy and safety of Lorcaserin
